In a 60-year-old woman with persistent hypercalcemia, elevated parathyroid hormone level, serum calcium of 10.8 mg/dL, vitamin D of 60 ng/mL, and osteopenia, what is the appropriate management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Primary Hyperparathyroidism: Proceed to Parathyroidectomy

This patient has primary hyperparathyroidism (PHPT) with osteopenia as a target organ complication, and should be referred to an endocrine surgeon for parathyroidectomy. 1

Diagnostic Confirmation

Your patient meets clear diagnostic criteria for PHPT:

  • Persistent hypercalcemia (calcium 10.8 mg/dL, normal upper limit ~10.5)
  • Elevated or inappropriately normal PTH (82 pg/mL in the setting of hypercalcemia)
  • Adequate vitamin D status (60 ng/mL) rules out vitamin D deficiency as a confounding factor

The vitamin D level of 60 ng/mL is particularly important here—it eliminates the common diagnostic pitfall where severe vitamin D deficiency can mask hypercalcemia or cause secondary hyperparathyroidism that mimics PHPT 1, 2. With adequate vitamin D repletion, the persistent elevation of both calcium and PTH confirms autonomous parathyroid function.

Surgical Indication: Osteopenia

The presence of osteopenia constitutes a target organ complication and is an absolute indication for surgery 1. The 2025 French expert consensus explicitly states that surgery is recommended "as soon as there are clinical consequences," and bone disease (osteopenia/osteoporosis) qualifies as such a consequence 1.

This is not "asymptomatic" PHPT—the patient has symptomatic disease affecting bone health. At age 60, a postmenopausal woman with osteopenia from PHPT faces progressive bone loss and fracture risk if left untreated.

Pre-Surgical Workup Required

Before surgery, complete the following assessments 1:

Renal evaluation:

  • Low-dose CT urography (preferred) or renal ultrasound to assess for nephrolithiasis or nephrocalcinosis
  • 24-hour urine calcium to identify hypercalciuria (another surgical indication)

Parathyroid localization studies:

  • First-line: Parathyroid ultrasound
  • Combined with either:
    • Double isotope scintigraphy (123I/99mTc-Sestamibi), OR
    • 18F-Choline PET-CT

If these studies fail to localize the adenoma, refer to an expert center for MRI or 4D CT 1.

Critical Caveat About Vitamin D

While your patient's vitamin D is adequate at 60 ng/mL, do NOT supplement with additional vitamin D preoperatively. Although vitamin D supplementation can be beneficial in PHPT patients with deficiency 3, there is documented risk of unmasking severe hypercalcemia when repleting vitamin D in PHPT patients 4. Since this patient already has sufficient levels, additional supplementation could precipitate a hypercalcemic crisis.

The one exception: if vitamin D were deficient, correction would be recommended specifically to prevent postoperative hungry bone syndrome, but only in patients with calcium <3.5 mmol/L (14 mg/dL) 1.

Why Not Medical Management?

Medical management with bisphosphonates or cinacalcet is reserved for patients who "cannot or do not want to undergo surgery" 5. These are second-line options:

  • Bisphosphonates (like alendronate) improve BMD but don't address the hypercalcemia
  • Cinacalcet lowers calcium but doesn't improve BMD and has only modest effects on PTH 5

Since your patient is a surgical candidate with a clear indication (osteopenia), definitive treatment with parathyroidectomy is superior—it addresses both the hypercalcemia and prevents further bone loss.

Surgical Referral

Refer to an experienced endocrine surgeon 1. The surgery should be performed at a center with expertise in parathyroid surgery, as outcomes are operator-dependent. If localization studies are negative or equivocal, refer to an expert center before attempting surgery 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.